Not Signed In -
Repaglinide |
Prandin |
Repaglinide Systematic (IUPAC) name S(+)2-ethoxy-4(2((3-methyl-1-(2-(1-piperidinyl) phenyl)-butyl) amino)-2-oxoethyl) benzoic acid Identifiers CAS number 135062-02-1 ATC code A10BX02 PubChem 65981 DrugBank APRD00439 Chemical data Formula C27H36N2O4 Mol. weight 452.586 g/mol Pharmacokinetic data Bioavailability 56% (oral) Protein binding >98% Metabolism Hepatic oxidation and glucuronidation (CYP3A4-mediated) Half life 1 hour Excretion Fecal (90% ...
Wikipedia - [full article]
Repaglinide Clinical Trials
- Effect of Repaglinide Versus Metformin Treatment in Non-Obese Patients With Type-2-Diabetes
ClinicalTrials.gov Identifier: NCT00118963 - Active, not recruiting
Diabetes Mellitus, Type 2
- Effect of Metformin Versus Repaglinide Treatment in Non-Obese Type 2 Diabetic Patients Uncontrolled by Diet
ClinicalTrials.gov Identifier: NCT00118950 - Completed
Diabetes Mellitus, Type 2
- Repaglinide for Adolescents With Cystic Fibrosis-Related Diabetes
ClinicalTrials.gov Identifier: NCT00231192 - Terminated
Diabetes
- A Double-Blind, Randomized, Parallel, Comparative Study to Evaluate the Efficacy and Safety of an Antidiabetic Agent Repaglinide for the Treatment of Type 2 Diabetes Mellitus Patients
ClinicalTrials.gov Identifier: NCT00336310 - Not yet recruiting
Diabetes Mellitus, Type 2
- Efficacy and Safety of Repaglinide and Metformin Combination Therapy in Type 2 Diabetes Failing on OAD
ClinicalTrials.gov Identifier: NCT00491725 - Completed
Non-Insulin Dependent Diabetes Mellitus
- Efficacy and Safety of Repaglinide, Glurenorm® and Glucobay® in Chineese Subjects With Type 2 Diabetes
ClinicalTrials.gov Identifier: NCT00568074 - Completed
Type 2 Diabetes Mellitus
- Efficacy and Safety of Repaglinide and Metformin Combined in Type 2 Diabetes
ClinicalTrials.gov Identifier: NCT00568984 - Completed
Type 2 Diabetes Mellitus
- Effect of Repaglinide and Metformin Combination Tablet or Rosiglitazone and Metformin in Fixed Dose Combination on Blood Glucose Control in Patients With Type 2 Diabetes
ClinicalTrials.gov Identifier: NCT00399711 - Completed
Diabetes Mellitus, Type 2
Resources
- Prandin (Drug Digest)
- Repaglinide (Drug Digest)
email this page
print this page
bookmark this page
feedback on this page
